Quercetin reversed lipopolysaccharide-induced inhibition of osteoblast differentiation through the mitogen-activated protein kinase pathway in MC3T3-E1 cells

Molecular Medicine Reports

Volumn 10, Issue 6, 2014, Pages 3320-3326

  Wang, Xin Chun ^a   Zhao, Nzhi Jun ^a   Guo, Chun ^b   Chen, Jing Tao ^a   Song, Jin Ling ^b   Gao, Li ^b  

^a HENAN UNIVERSITY   (China)

^b Luohe Vocational Technology College   (China)

Author keywords

Lipopolysaccharide; Mitogen activated protein kinase; Osteoblast; Osterix; Quercetin

Indexed keywords

LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; QUERCETIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL; APOPTOSIS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINE; DRUG EFFECTS; DRUG THERAPY; METABOLISM; MOUSE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; QUERCETIN; SIGNAL TRANSDUCTION;

EID: 84914169390     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2633     Document Type: Article

References (32)

1. Roodman GD: Advances in bone biology: the osteoclast. Endocr Rev 17: 308-332, 1996.
2. Nair SP, Meghji S, Wilson M, et al: Bacterially induced bone destruction: Mechanisms and misconceptions. Infect Immun 64: 2371-2380, 1996.
3. Orcel P, Feuga M, Bielakoff J and De Vernejoul MC: Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. Am J Physiol 264: E391-E397, 1993.
4. Chiang CY, Kyritsis G, Graves DT and Amar S: Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 67: 4231-4236, 1999.
5. Itoh K, Udagawa N, Kobayashi K, et al: Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol 170: 3688-3695, 2003.
6. Islam S, Hassan F, Tumurkhuu G, et al: Bacterial lipopolysaccharide induces osteoclast formation in RAW 264-7 macrophage cells. Biochem Biophys Res Commun 360: 346-351, 2007.
7. Mörmann M, Thederan M, Nackchbandi I, et al: Lipopolysaccharides (LPS) induce the differentiation of human monocytes to osteoclasts in a tumour necrosis factor (TNF) alpha-dependent manner: a link between infection and pathological bone resorption. Mol Immunol 45: 3330-3337, 2008.
8. Zou W and Bar-Shavit Z: Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17: 1211-1218, 2002.
9. Kadono H, Kido J, Kataoka M, et al: Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 67: 2841-2846, 1999.
10. Xing Q, Ye Q, Fan M, et al: Porphyromonas gingivalis lipopolysaccharide inhibits the osteoblastic differentiation of preosteoblasts by activating Notch 1 signaling. J Cell Physiol 225: 106-114, 2010.
11. Bandow K, Maeda A, Kakimoto K, et al: Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation. Biochem Biophys Res Commun 402: 755-761, 2010.
12. Ochi H, Hara Y, Tagawa M, et al: The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival. J Orthop Res 28: 657-663, 2010.
13. Wattel A, Kamel S, Mentaverri R, et al: Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 65: 35-42, 2003.
14. Woo JT, Nakagawa H, Notoya M, et al: Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol Pharm Bull 27: 504-509, 2004.
15. Siddiqui JA, Swarnkar G, Sharan K, et al: A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone. Osteoporos Int 22: 3013-3027, 2011.
16. Prouillet C, Mazière JC, Mazière C, et al: Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 67: 1307-1313, 2004.
17. Notoya M, Tsukamoto Y, Nishimura H, et al: Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur J Pharmacol 485: 89-96, 2004.
18. Matsuguchi T, Chiba N, Bandow K, et al: JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation. J Bone Miner Res 24: 398-410, 2009.
19. Gutiérrez-Venegas G, Jiménez-Estrada M and Maldonado S: The effect of flavonoids on transduction mechanisms in lipopolysaccharide-treated human gingival fibroblasts. Int Immunopharmacol 7: 1199-1210, 2007.
20. Guo C, Hou GQ, Li XD, et al: Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells. Cell Physiol Biochem 30: 123-136, 2012.
21. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
22. Kim HK, Cho SG, Kim JH, et al: Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation. Life Sci 84: 290-295, 2009.
23. Thunyakitpisal P, Alvarez M, Tokunaga K, et al: Cloning and functional analysis of a family of nuclear matrix transcription factors (NP/NMP4) that regulate type I collagen expression in osteoblasts. J Bone Miner Res 16: 10-23, 2001.
24. Kern B, Shen J, Starbuck M and Karsenty G: Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 276: 7101-7107, 2001.
25. Komori T, Yagi H, Nomura S, et al: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764, 1997.
26. Nakashima K, Zhou X, Kunkel G, et al: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29, 2002.
27. Fu H, Doll B, McNelis T and Hollinger JO: Osteoblast differentiation in vitro and in vivo promoted by Osterix. J Biomed Mater Res A 83: 770-778, 2007.
28. Kurata H, Guillot PV, Chan J and Fisk NM: Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng 13: 1513-1523, 2007.
29. Pearson G, Robinson F, Beers Gibson T, et al: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183, 2001.
30. Xia Z, Dickens M, Raingeaud J, et al: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
31. Fister S, Günthert AR, Aicher B, et al: GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax. Cancer Res 69: 6473-6481, 2009.
32. Park GB, Kim YS, Lee HK, et al: Endoplasmic reticulum stress-mediated apoptosis of EBV-transformed B cells by cross-linking of CD70 is dependent upon generation of reactive oxygen species and activation of p38 MAPK and JNK pathway. J Immunol 185: 7274-7284, 2010.